Omeros | OMER - Debt

Omeros reported $442.44M in Debt for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Debt Change
Acelrx Pharmaceuticals ACRX:US USD 7.89M 2M
Adma Biologics ADMA:US USD 142.83M 1.47M
Alnylam Pharmaceuticals ALNY:US USD 1.02B 967K
Biomarin Pharmaceutical BMRN:US USD 1.09B 3.46M
Cytokinetics CYTK:US USD 611.62M 888K
Dynavax Technologies DVAX:US USD 221.58M 275K
Heron Therapeutics HRTX:US USD 149.23M 52K
Insmed INSM:US USD 1.16B 348.29M
Intercept Pharmaceuticals ICPT:US USD 332.67M 365K
Knight Therapeutics Inc GUD:CN CAD 77.7M 38.64M
Omeros OMER:US USD 442.44M 2.62M
Pacira Pharmaceuticals PCRX:US USD 689.47M 58.4M
Regulus Therapeutics RGLS:US USD 4.51M 33K
Rockwell Medical RMTI:US USD 15.1M 1.91M
Sarepta Therapeutics SRPT:US USD 1.54B 1.52M
United Therapeutics UTHR:US USD 800M 0
Vertex Pharmaceuticals VRTX:US USD 471.6M 29.3M